Diabetic Foot Ulcer Clinical Unit
NIDDK Diabetic Foot Consortium Clinical Research Unit
['FUNDING_U01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11257687
This program aims to bring quick bedside tests (biomarkers) into clinics to help people with diabetes and foot ulcers get faster, clearer care.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11257687 on ClinicalTrials.gov |
What this research studies
If you have diabetes and a foot ulcer, this clinical unit works to collect samples and test simple markers that might show if a wound is infected or not healing. The team runs a master protocol with smaller substudies to finalize and standardize these biomarker tests and how they would be used in clinic visits. The project links clinics, lab testing, and data analysis so results can be used at the point of care rather than waiting for long lab turnaround. The goal is to move promising tests from early work into real-world use across participating sites.
Who could benefit from this research
Good fit: Adults with diabetes who currently have or recently healed diabetic foot ulcers, or who are receiving care at participating wound clinics, are the most likely candidates to join.
Not a fit: People without diabetes, without foot wounds, or those unable to attend participating clinical sites are unlikely to benefit directly from this program.
Why it matters
Potential benefit: Successful point-of-care biomarkers could lead to earlier problem detection, more targeted treatments, and fewer amputations for people with diabetic foot ulcers.
How similar studies have performed: Earlier pilot work and the first cycle of the Diabetic Foot Consortium showed promising biomarker leads, but larger validation and implementation are still needed.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOLMES, CRYSTAL MURRAY — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: HOLMES, CRYSTAL MURRAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.